The impact of the 21-gene Recurrence Score assay on clinical decision-making in node-positive (up to 3 positive nodes) estrogen receptor-positive breast cancer patients - Stemmer, S M; Klang, S H; Ben-Baruch, N (Breast Cancer Res Treat, 2013)
et al.